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comparison of one result from a subject with the unstratified generally applicable reference interval will be a good guide to disease, since an unusual value for a subject will likely lie outside the reference limits and so be picked up by the clinician and simple computer flagging systems.
We do not consider that Gunn's analogy provides objective information to refute our suggestion. In comparing serum creatinine and creatinine clearance, we are investigating two alternatives for diagnosis of one condition, that is, renal impairment. Comparing calcium and PTH for the diagnosis of hyperparathyroidism is an interesting example. Gunn suggests that the study of Nussbaum et al. 4 shows large overlap of PTH results between patients with and without hyperparathyroidism. In fact, it is easy to calculate that the sensitivity is 95% when the specificity is 100 0 1. , and the specificity is 86% when the sensitivity is 100%; thus there is only small overlap between healthy subjects and patients with hyperparathyroidism. Would that all tests in our repertoire possessed these nosological performance characteristics. In addition, to quote from the publication, 'assay results for 37 individuals with surgically proven hyperparathyroidism were completely resolved from those for 24 patients with hypercalcaemia of malignancy'. Moreover, PTH was not compared with calcium as a criterion for diagnosis: all of the patients studied had hypercalcaemia. Furthermore, it should be noted that the data on intra-and inter-individual variation of PTH were obtained by Gunn and co-workers/ on only two specimens taken one week apart. In addition, unstratified serum creatinine and creatinine clearance corrected for surface area have very different indices of individuality (0'29 and 1,10, repsectively). In contrast, the indices for PTH and calcium are very similar, as far as can be deduced from the data quoted by Gunn." ELIZABETH A simple method for determination of plasma thiocyanate
Falkensson et al,' claim their preference for assaying plasma because 'it is easily collected under field conditions'. This assertion is doubtful, accepting the reluc-
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tance people show in giving blood for investigation studies, particularly in developing countries, and its potential as a vector for hepatitis and AIDS. On several occasions (e.g. Bourdoux et al. 2 ) , we have advocated the measurement of thiocyanate in urines rather than serum or plasma. Indeed, in Zaire we observed very high thiocyanate levels resulting from massive consumption of poorly detoxified cassava. These studies showed that thiocyanate levels in serum paralleled that in urine up to about 175~mol/L but above this threshold value, serum thiocyanate plateaued while urinary thiocyanate still increased.
The authors present an apparently new technique for measuring plasma thiocyanate although this technique is similar to the one originally proposed by Asmus and Garschagen (Fresenius' Z Anal Chern 1953; 138: 414).
They discuss interfering compounds present 'mainly in the urine'. Do they have any information on the amount of such compounds in serum and urine respectively? They do not provide any information regarding the real extent of such interference in serum measurements and possibly on the nature of these compounds? Paradoxically, they justify the development of the proposed technique because of the poor specificity of other methods. If their technique is not restricted to thiocyanate alone, this should be clearly stated.
Finally, the assessment of the proposed technique rests on the comparison of eight samples with a technique they have previously reported! P BOURDOUX
The authors reply:
On behalf of my co-authors I welcome the opportunity to comment on Dr Bourdoux's letter. We described in our paper a modification of a method earlier reported from our laboratory! for thiocyanate assay of serum, plasma or urine. The modified method is applicable to serum or plasma, but not urine due to interfering compounds present in the latter. Urinary thiocyanate can be analysed by methods which are not affected by other compounds present in urine, but these methods require facilities not available under field conditions, although urine samples collected in the field may later be assayed in a well-equipped laboratory. Dr Bourdoux is also of the opinion that our method is similar to that of Asmus and Garschagen. We disagree! It is true that we used barbituric acid for the development of the Konig chromogen as proposed by Asmus and Garschagen. However, these authors used chloramine T for the initial chlorination of thiocyanate to cyanogen chloride. As thiocyanate reacts rather slowly with chloramine T, ferric ions had to be added as a catalyst. This makes their method vulnerable to compounds binding with iron and, as far as we are aware, this method has not been applied to biological samples. One original feature of our method is that we use soldium hypochlorite in the chlorination step. Sodium hypochlorite reacts very rapidly with thiocyanate and thus no catalyst is required.
The validity of our original method was established as described in our earlier report. I Comparison of the results obtained on plasma samples assayed by this specific method and of the modified method described in our recent paper (Ann Clin Biochem 1988; 25: 422-3) suggests our modified method is not subject to any significant interference from compounds present in plasma. Is freeze-dried serum suitable for inter-laboratory standardisation of fructose assays?
The recent article by Hill (Ann Clin Biochem 1988; 25: 435-9) provided some interesting data on the use of various standards as a means of improving betweenlaboratory variation in serum fructosamine assays. Factors affecting the use of l-deoxy-l-rnorpholinofructose as a standard, such as dye concentration, temperature and buffer pH have previously been discussedI and are reiterated in the article. No coherent explantation was offered for the failure of a freeze-dried serum calibrator to produce the expected improvement in precision for a non-diabetic human pool. I would suggest that assay wavelength is playing a major part in the variation between laboratories, particularly when using a freeze-dried preparation as a standard. The original wavelength of 530 nm used by Johnson et al. 2 is not available on the Baker Encore centrifugal analyser, so I investigated the variation in change of absorbance between 10 and 15 min at different wavelengths and with a variety of materials. The assay was performed with a Roche kit (pH 10'35) at 37 DC. The measured absorbance changes relative to that at 550 nm are shown in Fig. I .
The most marked feature is the difference in the relative absorbances at 520 and 550 nm for the various materials. The two freeze-dried preparations, one bovine-based (Technicon) and one human-based (Dade) had exactly the same, large difference in absorbance at these two wavelengths. The difference for the Roche glycated albumin standard, however, was much less, smaller than the observed difference in normal human specimens. The use of any of these calibrators would inevitably produce inter-laboratory variation for human serum samples iflaboratories employ difference wavelengths for the fructosamine assay.
The absorbance change profile of the liquid control serum Decision 2 (Beckman) closely matched that of normal samples. It would therefore probably be suitable 60~~----,-~~~-~-~....--j 480 500 520 560 560 580 600 620 as an inter-laboratory calibrant which would minimise the effect of wavelength. It has been used as a working standard in a routine asay.! The influence of wavelength has been investigated for normal human serum and human albumin and a wavelength of 540 nm recommended," though that study did not investigate freeze-dried serum and measured the absorbance change between 5 and 7 min rather than the more usual interval between 10 and 15 min. The time interval chosen may well affect the relative absorbance readings since the absorbance profiles for the interval 0-15 min are different 10 those in Fig. I , the curves co-inducing more closely.
The use of a liquid-based secondary serum standard does not avoid the problem of assigning a value to this standard, but may well prove useful in locally organised quality control schemes and inter-laboratory standardisation. Freeze-dried specimens are unlikely to be useful in achieving these aims.
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